Jonathan Heistein, MD
Plastic Surgery · Fort Worth, TXNPI 1972590404
Payments from drug & device makers
Across 149 payments — averaging $39.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Mentor Worldwide LLC$1K
- Davol Inc.$685
- Musculoskeletal Transplant Foundation Inc.$416
- Galderma Laboratories, L.p.$254
- Merz North America, Inc.$125
- plus $442 from 10 others
Across 4 payments — averaging $17,934 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Musculoskeletal Transplant Foundation Inc.$72K
What the payments were for
- Consulting fees$401%
- Speaking & faculty fees$60010%
- Food & beverage$5,14488%
- Education$571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $2,788 |
| Mentor Worldwide LLC | 76 | $1,131 |
| Davol Inc. | 5 | $685 |
| Musculoskeletal Transplant Foundation Inc. | 5 | $416 |
| Galderma Laboratories, L.p. | 3 | $254 |
| Merz North America, Inc. | 1 | $125 |
| Medical Device Business Services, Inc. | 1 | $125 |
| Sientra, Inc. | 4 | $99 |
| Integra Lifesciences Corporation | 2 | $62 |
| Medtronic | 1 | $40 |
| Tepha Inc | 1 | $23 |
| KCI USA, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Revance Therapeutics, Inc. | 1 | $19 |
| W. L. Gore & Associates, Inc. | 1 | $18 |
| Motiva USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,841 in reported general payments places this provider in the 65th percentile of 337 plastic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $190 |
| Cephalexin | 36 | $156 |
| Cyclobenzaprine Hcl | 23 | $153 |
| Promethazine Hcl | 21 | $37 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Fort Worth
- Steven CampFort Worth$173K
- Emily KirbyFort Worth$53K
- Danielle LeblancFort Worth$22K
- Rodney RohrichDallas$1.7M
- Younghoon ChoHouston$1.3M
- David AdelmanHouston$405K
- Warren EllsworthHouston$359K
- Regina FearmontiSan Antonio$340K
- Anthony EchoHouston$322K
- Camille CashHouston$227K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.